Amgen Inc Stock Forecast for 2023 - 2025 - 2030

Updated on 12/06/2023

Stock Rating
7
Price Target
$287.00
Consensus
Outperform
Upside
6.55%
Analysts
11
Stock Rating
7
Upside
6.55%
Analysts
11
Price Target
$287.00

Amgen Inc Stock Forecast and Price Target

Amgen Inc's most recent price target of $287.00 for 2023 was provided by eleven renowned analysts over the past few months, with an average prediction of $287.00. If this prediction is correct, Amgen Inc's stock could rise by 6.55 percent from its current trading price. The potential increase for the stock is $287.00 per share, with a possible range of $185.00 to $336.00. If you are interested in AMGN stock, you should also look at its competitors.

$287.00

6.55% Upside

Outperform
Outperform

Amgen Inc Fair Value Forecast for 2023 - 2025 - 2030

Amgen Inc's Price has increased by 19.37% In the last three years, going from $204.81 to $244.48. In the next year, analysts expect Fair Value to reach $266.04 – an increase of 8.82%. For the next eight years, the forecast is for Fair Value to grow by 36.40%.

2023 Fair Value Forecast
$266.04
2024 Fair Value Forecast
$292.71
2025 Fair Value Forecast
$300.45
2026 Fair Value Forecast
$312.47
2027 Fair Value Forecast
$325.18
2028 Fair Value Forecast
$326.15
2029 Fair Value Forecast
$314.96
2030 Fair Value Forecast
$333.48
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABBV Stock Forecast AbbVie Outperform 10
$146.38 Buy/Sell $167.35 14.09%
GILD Stock Forecast Gilead Sciences Inc Outperform 11
$79.36 Buy/Sell $90.39 14.04%
ALXN Stock Forecast Alexion Pharmaceuticals - 15
$182.50 Buy/Sell $177.38 -100.00%
BIIB Stock Forecast Biogen Inc Outperform 11
$233.87 Buy/Sell $322.44 32.98%
BMRN Stock Forecast BioMarin Pharmaceutical Inc Outperform 10
$94.16 Buy/Sell $115.79 15.21%

Amgen Inc Revenue Forecast for 2023 - 2025 - 2030

Amgen Inc's Revenue has increased by 12.67% In the last three years, going from $23.36B to $26.32B. In the next year, analysts expect Revenue to reach $27.32B – an increase of 3.78%. For the next eight years, the forecast is for Revenue to grow by 6.58%.

2023 Rev Forecast
$27.32B
2024 Rev Forecast
$28.62B
2025 Rev Forecast
$28.96B
2026 Rev Forecast
$29.35B
2027 Rev Forecast
$29.95B
2028 Rev Forecast
$29.64B
2029 Rev Forecast
$28.43B
2030 Rev Forecast
$28.05B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
INCY Stock Forecast Incyte Corp Outperform 9
$55.42 Buy/Sell $83.59 47.96%
EXEL Stock Forecast Exelixis Inc Outperform 16
$21.93 Buy/Sell $25.02 23.12%
ARNA Stock Forecast Arena Pharmaceuticals - 6
$99.99 Buy/Sell $100.00 -100.00%

Amgen Inc Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Amgen Inc's Dividend per Share has grown, increasing from $5.80 to $7.76 – a growth of 33.79%. The next year looks promising for Amgen Inc, with analysts predicting Dividend per Share of $8.28 – an increase of 6.70%. Over the next eight years, experts anticipate that Amgen Inc's Dividend per Share will grow at a rate of 62.89%.

2023 DPS Forecast
$8.28
2024 DPS Forecast
$9.30
2025 DPS Forecast
$9.81
2026 DPS Forecast
$10.70
2027 DPS Forecast
$11.14
2028 DPS Forecast
$11.14
2029 DPS Forecast
$11.87
2030 DPS Forecast
$12.64
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BPMC Stock Forecast Blueprint Medicines Outperform 6
$72.42 Buy/Sell $119.23 17.37%
CCXI Stock Forecast ChemoCentryx - 8
$51.99 Buy/Sell $52.00 -100.00%
ACAD Stock Forecast ACADIA Pharmaceuticals Outperform 6
$21.38 Buy/Sell $29.50 59.03%

Amgen Inc Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last three years, Amgen Inc's Free Cash Flow has grown from $8.53B to $9.11B – a 6.81% increase. Next year, analysts are expecting Free Cash Flow to reach $10.40B – an increase of 14.11%. Over the next eight years, the forecast is for Free Cash Flow to grow by 34.60%.

2023 FCF Forecast
$10.40B
2024 FCF Forecast
$11.22B
2025 FCF Forecast
$11.38B
2026 FCF Forecast
$11.92B
2027 FCF Forecast
$12.85B
2028 FCF Forecast
$12.95B
2029 FCF Forecast
$12.66B
2030 FCF Forecast
$12.27B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
FOLD Stock Forecast Amicus Therapeutics Outperform 7
$11.02 Buy/Sell $17.90 76.95%
DRNA Stock Forecast Dicerna Pharmaceuticals - 7
$38.01 Buy/Sell $35.06 -100.00%
ARWR Stock Forecast Arrowhead Pharmaceuticals Outperform 7
$23.79 Buy/Sell $56.62 126.99%

Amgen Inc Net Income Forecast for 2023 - 2025 - 2030

In the last three years, Amgen Inc's Net Income has seen a drop from $7.84B to $6.55B – a 16.45% decrease. For the next year, analysts are expecting Net Income to reach $10.25B – an increase of 56.44%. Over the next eight years, experts predict that Net Income will grow by 50.36%.

2023 NI Forecast
$10.25B
2024 NI Forecast
$11.03B
2025 NI Forecast
$11.12B
2026 NI Forecast
$11.35B
2027 NI Forecast
$11.12B
2028 NI Forecast
$10.76B
2029 NI Forecast
$10.04B
2030 NI Forecast
$9.85B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CBAY Stock Forecast CymaBay Therapeutics Buy 8
$20.86 Buy/Sell $24.82 15.05%
DVAX Stock Forecast Dynavax Technologies Buy 11
$13.40 Buy/Sell $25.00 86.57%
VKTX Stock Forecast Viking Therapeutics Buy 5
$17.24 Buy/Sell $34.00 103.02%

Amgen Inc EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Amgen Inc's EBITDA has grown by 14.72%, rising from $11.76B to $13.49B. For next year, analysts predict EBITDA of $16.28B, which would mean an increase of 20.70%. Professionals believe that By 2030, Amgen Inc's EBITDA will fall to $13.09B – a 2.94% decrease from its current value.

2023 EBITDA Forecast
$16.28B
2024 EBITDA Forecast
$16.97B
2025 EBITDA Forecast
$16.21B
2026 EBITDA Forecast
$15.23B
2027 EBITDA Forecast
$15.12B
2028 EBITDA Forecast
$15.25B
2029 EBITDA Forecast
$14.39B
2030 EBITDA Forecast
$13.09B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CLDX Stock Forecast Celldex Therapeutics Buy 11
$31.60 Buy/Sell $63.29 115.19%
VCEL Stock Forecast Vericel Buy 8
$33.62 Buy/Sell $42.58 27.90%
IOVA Stock Forecast Iovance Biotherapeutics Buy 4
$6.38 Buy/Sell $20.42 197.81%

Amgen Inc EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Amgen Inc's EBIT has grown by 3.58%, rising from $9.72B to $10.07B. For next year, analysts predict EBIT of $13.01B, which would mean an increase of 29.19%. Over the next eight years, experts predict that Amgen Inc's EBIT will grow at a rate of 26.09%.

2023 EBIT Forecast
$13.01B
2024 EBIT Forecast
$13.71B
2025 EBIT Forecast
$13.77B
2026 EBIT Forecast
$13.75B
2027 EBIT Forecast
$13.89B
2028 EBIT Forecast
$13.59B
2029 EBIT Forecast
$12.89B
2030 EBIT Forecast
$12.70B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AGIO Stock Forecast Agios Pharmaceuticals Outperform 9
$22.55 Buy/Sell $53.75 72.95%
BCRX Stock Forecast BioCryst Pharmaceuticals Outperform 7
$5.51 Buy/Sell $15.20 99.64%
SAGE Stock Forecast Sage Therapeutics Hold 6
$20.85 Buy/Sell $25.28 5.52%

Amgen Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030

Amgen Inc's EPS has increased by 19.37% In the last three years, going from $14.82 to $17.69. In the next year, analysts expect EPS to reach $19.25 – an increase of 8.82%. For the next eight years, the forecast is for EPS to grow by 36.40%.

2023 EPS Forecast
$19.25
2024 EPS Forecast
$21.18
2025 EPS Forecast
$21.74
2026 EPS Forecast
$22.61
2027 EPS Forecast
$23.53
2028 EPS Forecast
$23.60
2029 EPS Forecast
$22.79
2030 EPS Forecast
$24.13
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ARDX Stock Forecast Ardelyx Buy 11
$5.14 Buy/Sell $9.64 94.55%
XNCR Stock Forecast Xencor Buy 6
$19.26 Buy/Sell $39.71 89.51%
MNKD Stock Forecast MannKind Buy 10
$3.59 Buy/Sell $6.92 88.02%